Z, Y., Z, H., Y, W., M, B., Y, Z., A, P., . . . MA, N. (2026). Targeting STK17B kinase activates ferroptosis and suppresses drug resistance in multiple myeloma. Blood, 147(1), 48. https://doi.org/10.1182/blood.2025029950
Chicago Style (17th ed.) CitationZ, Yan, et al. "Targeting STK17B Kinase Activates Ferroptosis and Suppresses Drug Resistance in Multiple Myeloma." Blood 147, no. 1 (2026): 48. https://doi.org/10.1182/blood.2025029950.
MLA (9th ed.) CitationZ, Yan, et al. "Targeting STK17B Kinase Activates Ferroptosis and Suppresses Drug Resistance in Multiple Myeloma." Blood, vol. 147, no. 1, 2026, p. 48, https://doi.org/10.1182/blood.2025029950.
Warning: These citations may not always be 100% accurate.